Barclays Maintains Overweight on Exelon, Raises Price Target to $44

Benzinga · 10/15 18:04
Barclays analyst Nicholas Campanella maintains Exelon (NASDAQ:EXC) with a Overweight and raises the price target from $41 to $44.